Basic Information
ID: ALA4370051
Type: Unassigned
Description: Drug metabolism in sodium phosphate buffer assessed as (2R,5S,8S,14S,17S,21S,44S)-8-((1H-indol-3-yl)methyl)-2-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)(methyl)carbamoyl)-5,14-dibutyl-3-methyl-4,7,10,13,16,19,23,32,41,46-decaoxo-17-(4-(sulfomethyl)benzyl)-25,28,34,37-tetraoxa-3,6,9,12,15,18,22,31,40,45-decaazadohexacontane-1,21,44,62-tetracarboxylic acid formation at 1 mM at pH 7.4 at 37 degC after 1 to 2 weeks by UHLPC-UV analysis
Activity Charts
Bioactivity
Activity Types for Assay ALA4370051
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 1849.17 |